-
1
المؤلفون: Jeffer L de Moraes, C. Michael Gibson, Andre Feldman, Thiago Ceccatto de Paula, Renato D. Lopes, Renata Junqueira Moll-Bernardes, Vitor A. Loures, Jacqueline Miranda, Rafael A. M. Domiciano, Ricardo G G de Oliveira, Rodrigo M Dionísio, Denilson Campos de Albuquerque, Márcia Noya-Rabelo, Andréa Silvestre de Sousa, Noara B Ribeiro, Pedro Gabriel Melo de Barros e Silva, Ariane Vieira Scarlatelli Macedo, Cleverson Neves Zukowski, Olga Ferreira de Souza, Lilian Mazza, Bárbara Elaine de Jesus Abufaiad, Thyago A. B. Furquim, John H. Alexander, Alan M Hamilton, Guilherme D'Andréa Saba Arruda, Karla G. D. Giusti, Bruno Santana Bandeira, Tiago Mendonça dos Santos, Italo Bruno dos Santos Sousa, Christopher B. Granger, João Luiz Fernandes Petriz, Angelina Camiletti, Fabio Augusto de Luca, Adriana M Pimentel
المصدر: JAMA
مصطلحات موضوعية: medicine.medical_specialty, medicine.medical_treatment, Angiotensin-Converting Enzyme Inhibitors, 01 natural sciences, law.invention, Angiotensin Receptor Antagonists, Electrocardiography, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, law, Interquartile range, Internal medicine, Humans, Medicine, 030212 general & internal medicine, Myocardial infarction, 0101 mathematics, Adverse effect, Original Investigation, Brugada Syndrome, SARS-CoV-2, business.industry, 010102 general mathematics, COVID-19, General Medicine, Odds ratio, medicine.disease, Hospitals, Discontinuation, Respiratory failure, Hemodialysis, business
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::374d59b1cfbf85d0a599b8b2f776f46b
https://doi.org/10.1001/jama.2020.25864